Cullen Investment Group, Ltd.
Source: SEC Form 13F · as of Mar 2026Cullen Investment Group, Ltd. holds 16 biotech & pharma companies tracked by BioSniper, totaling $74.5M in value as of Mar 2026 (SEC Form 13F).
Companies held
16
Total value held
$74.5M
| Company | Shares | Value |
|---|---|---|
| PMPhilip Morris International Inc | 97,072 | $16.0M |
| MRKMerck & Co., Inc. | 112,739 | $13.6M |
| LLYELI LILLY & Co | 11,798 | $10.9M |
| NVSNovartis AG | 50,305 | $7.7M |
| JNJJOHNSON & JOHNSON | 25,361 | $6.2M |
| MCKMcKesson Corporation | 6,963 | $6.0M |
| IQVIQVIA Holdings Inc. | 20,155 | $3.4M |
| ABBVAbbVie Inc. | 12,863 | $2.8M |
| AMGNAMGEN INC | 7,693 | $2.7M |
| GILDGILEAD SCIENCES, INC. | 12,691 | $1.8M |
| UNHUnitedHealth Group Incorporated Common Stock (DE) | 3,962 | $1.1M |
| CORCencora Inc. | 3,109 | $977K |
| PFEPFIZER INC | 16,095 | $452K |
| NVONovo Nordisk A/S | 10,000 | $368K |
| ABTABBOTT LABORATORIES | 3,092 | $317K |
| ICLRICON plc | 2,173 | $240K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.